Skip to content
DataLookout
Menu

FLOW-DCBNCT07852689

Comparison of Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary Intervention Strategies

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened
    • Start date changed from estimate of Nov 9, 2026 to Nov 16, 2026
    • Site details revised at 4 of 4 sites
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Distal FFR at the target or culprit lesion
Timeframe: 6 months (±30 days; up to 9 months if necessary)

Secondary (18)

Trans-lesion ΔFFR
Intermediate-term pressure gain (exploratory)
Overall stent burden
Quantitative coronary angiography (QCA) measures
Physiological outcomes by follow-up timing (exploratory)
Show 13 moreShow less
Cardiovascular death
All-cause death
Target-Vessel Myocardial Infarction
Nonfatal Myocardial Infarction
Clinically Indicated Target-Lesion Revascularization
Clinically Indicated Target-Vessel Revascularization
Any Revascularization
Definite or Probable Lesion or Stent Thrombosis
Cardiovascular Death or Target-Vessel Myocardial Infarction
All-Cause Death or Nonfatal Myocardial Infarction
Target-Vessel Failure
Target-Lesion Failure
Clinically Relevant Bleeding

Arms and interventions

DCB-based PCI groupExperimental

In the DCB-based PCI group, lesion preparation may include conventional, non-compliant, cutting, or scoring balloons and, when needed, other calcium-modification techniques. An adequately prepared lesion has expansion with a balloon-to-vessel diameter ratio of at least 0.90, residual diameter stenosis of 30% or less, TIMI grade 3 flow, and no flow-limiting dissection or risk of vessel closure. When these conditions are met, the operator will use a paclitaxel-coated DCB (SeQuent Please NEO), sized approximately 1:1 to the reference vessel and covering the prepared segment. DCB delivery within 30 seconds and inflation for 30-60 seconds are recommended when clinically tolerated. DES implantation is permitted for inadequate flow, residual stenosis greater than 30%, substantial recoil, a major dissection, or another procedural reason requiring immediate stenting. Such stenting is part of the assigned DCB-based strategy, not a treatment crossover.

DES-only PCI groupActive comparator

In the DES-only PCI group, the target or culprit lesion will be treated with a contemporary newer-generation DES according to clinical practice.

Devices: Drug-coated balloon-based intervention, Drug-eluting stent-based intervention

Sites

4 sites in 1 country